Oxford-led researchers develop a low-cost rapid test to identify heat-damaged vaccines
17 December 2025
Researchers from Medicine Quality Research Group, the University of Oxford and their collaborators have developed and evaluated a novel low-cost, rapid method to identify heat-exposed sucrose-containing vaccines without the need for sophisticated laboratory equipment.
Rapid, low-cost tests can help prevent child deaths from contaminated medicinal syrups
5 December 2025
Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.
Data platform will play a vital role in future VL research
3 December 2025
A new publication authored by IDDO’s Visceral Leishmaniasis (VL) Scientific Advisory Committee sets out a research agenda for VL, and describes how IDDO established and developed a data platform that enables data reuse for crucial historical data.
‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn
2 December 2025
Infectious diseases such as malaria, dengue, and tuberculosis are considered to pose as great a challenge to global health as new or emerging pathogens, according to a major international study led by The Global Health Network at Oxford’s Nuffield Department of Medicine and commissioned by Wellcome.
Shaping Oxford’s Vision for Global Health in a Period of Turbulence
25 November 2025
The first Oxford Global Health Summit united colleagues across the University to drive a bold, collaborative vision for global health.
Oxford Global Health welcomes Ghana’s High Commissioner for engagement on malaria and strengthening collaboration
25 November 2025
Oxford Global Health welcomed Ghana’s High Commissioner and her delegation for a day of discussions on malaria elimination and future collaboration.
GRAM invites researchers to explore AMR data in repository
13 November 2025
After gathering one of the largest collections of individual patient data on antimicrobial resistance (AMR) in the world, the Global Research on Antimicrobial Resistance (GRAM) Project is now inviting researchers to use this valuable resource in their own studies. The AMR data repository, hosted by the Infectious Diseases Data Observatory (IDDO), now covers nearly 70 countries and 250,000 patients, after launching last year to provide a secure, sustainable platform for global AMR data sharing. Holdings currently include 38 datasets from 24 different (GRAM) Project collaborators.
New study evaluates accuracy of rapid diagnostic tests for malaria
7 November 2025
A new study, published in Malaria Journal, assessed the accuracy of rapid malaria tests (RDTs) across 12 sites in India and found that these tests were sub-optimal for detecting P. vivax malaria.
Oxford strengthens strategic partnerships with Vietnam in health, education and climate innovation
31 October 2025
The University of Oxford has signed three landmark agreements with leading Vietnamese partners, deepening collaboration across healthcare, higher education and sustainable aviation. The Tam Anh Research Institute has signed a Memorandum of Understanding with the International Health and Tropical Medicine Group from NDM Centre for Global Health Research, establishing the Tam Anh Oxford Partnership (TOP).
Ensitrelvir shows strong antiviral activity against COVID-19 in first head-to-head comparison with Paxlovid
28 October 2025
The oral antiviral ensitrelvir is a highly effective treatment for COVID-19, showing potent in-vivo antiviral activity comparable to ritonavir-boosted nirmatrelvir (Paxlovid), say MORU, Mahidol and University of Oxford researchers in a major international study published in The Lancet Infectious Diseases.
Innovative Oxford child anxiety treatment to be rolled out internationally
21 October 2025
An effective online treatment for childhood anxiety developed by a team at the University of Oxford is to be adapted and tested in five countries in Asia and South America, with the aim of driving widespread implementation in the future.
Anne Makena, Africa Oxford Initiative Co-Director steps down
15 October 2025
Dr Anne Makena, has announced her decision to transition from the role of Co-Director of the Africa Oxford initiative. A founding member of the Africa Oxford Initiative, Dr Makena has overseen the establishment and rapid growth of AfOx from conceptualisation to scaling for almost a decade.
Caesar Atuire awarded full professorship
14 October 2025
Philosopher and Health Ethicist Caear Atuire has been awarded the title of Professor, in recognition of his research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
FD-TACT malaria treatment trial launches patient recruitment in Rwanda
8 October 2025
A Phase 3 pivotal trial, led by MORU and funded by Japan’s Global Health Innovative Technology Fund (GHIT), has begun to evaluate a novel fixed-dose triple artemisinin-based combination treatment (FD-TACT) for uncomplicated Plasmodium falciparum malaria.
Kevin Marsh awarded RSTMH’s 2025 Sir Patrick Manson Medal
1 October 2025
The Royal Society of Tropical Medicine and Hygiene's most prestigious award, the Sir Patrick Manson Medal, is being given this year to Professor Kevin Marsh, a Malariologist and Global Health Researcher. Professor Marsh is the Director of the Africa Oxford Initiative and Senior Adviser Science for Africa Foundation at the University of Oxford. His major research interests focus on immunity to and pathogenesis of malaria, and he has a particular interest in supporting science and scientific leadership across Africa.
New study find treatment for Chagas disease is excessive
23 September 2025
A new study has found the current recommended treatment for Chagas disease could be given over a substantially shorter time period and still be as effective.
Tracking resistance: Mapping the spread of drug-resistant malaria
20 August 2025
On World Mosquito Day, Dr Lucy Harrison, postdoctoral researcher at Oxford’s Infectious Diseases Data Observatory (IDDO) at the Centre for Tropical Medicine and Global Health, reflects on the global impact of the mosquito and her research into malaria drug resistance.
Severe nurse shortages in Kenya undermine newborn care, despite advancements
14 August 2025
A multi-disciplinary study by KEMRI-Wellcome Trust, Harnessing Innovation in Global Health for Quality Care (HIGH-Q), has revealed how workforce issues influence the quality of care in newborn units. The research highlighted the effect of severe nurse staffing shortages in Kenyan hospitals as a major obstacle to providing quality care for newborns.
Simple new method that measures viral clearance means antibody treatments for COVID and ‘flu can be quickly assessed for effectiveness, say MORU researchers
7 August 2025
Measuring the rate of viral clearance from the back of the mouth in patients with mild infections can be used to determine quickly and inexpensively if an antibody is effective in future COVID-19, influenza and other respiratory virus pandemics, say researchers in a letter published today in The Lancet.
Global Action Needed to Tackle Noma Disease
5 August 2025
Greater surveillance and well-designed epidemiological studies for noma should be a research priority. A new BMJ Global Health paper reveals major gaps in research on noma, a severe and often fatal oral disease affecting children in low-resource settings. Despite WHO recognition of noma as a neglected tropical disease, limited data exists on its causes, burden, and treatment. The study calls for standardised reporting, increased surveillance, and improved early detection. Conducted by IDDO and WHO, the review analysed 366 studies to provide a comprehensive foundation for future research and policy action.